Friday, August 28, 2015 7:37:51 PM
I agree, you were just the messenger, and I gave you props for having the message -- as well as for going to the meeting where you reported the focus was on 'going public.'
I did not mean to challenge the accuracy of your representation, sorry if it felt that way. I can't imagine why you would present anything other than what you were told.
Hitting 'public replay' is the easiest way to present my data and enable other readers to reference the data upon which I'm commenting.
In the future, will try to remember not to do 'public reply' on your messages, but do need to reference the information in them, I'll just try to do it a different way.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM